A Blast From the Past: Abdominal Wall Amyloidosis Due to Enfuvirtide Injections

Enfuvirtide was the first marketed fusion inhibitor that worked by binding to glycoprotein 41 of the HIV envelope, preventing the conformational changes required for HIV fusion with CD4+ T cells. Due to its novel mechanisms of action, it was frequently used in the past as part of regimens for the in...

Descripción completa

Detalles Bibliográficos
Autores principales: Costiniuk, Cecilia, Bourgault, Anne-Marie, Maedler-Kron, Chelsea, Feldman, Liane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483575/
https://www.ncbi.nlm.nih.gov/pubmed/37692653
http://dx.doi.org/10.7759/cureus.43126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483575/
https://www.ncbi.nlm.nih.gov/pubmed/37692653
http://dx.doi.org/10.7759/cureus.43126

Ejemplares similares